Abstract:BACKGROUND:Because of critical organ shortage, transplant professionals have utilized living donor liver transplantation (LDLT) in recent years. We summarized our experience in adult-to- adult LDLT with grafts of right liver lobe by a modified technique. METHODS:From January 2002 to August 2005, 24 adult patients underwent living donor liver transplantation with grafts of the right liver lobe at West China Hospital, Sichuan University, China. Twenty-two patients underwent modified procedures designed to improve the reconstruction of the right hepatic vein and the tributaries of the middle hepatic vein by interposing a great saphenous vein (GSV) graft and the anastomosis of the hepatic arteries and bile ducts. RESULTS:No severe complications and death occurred in all donors. In the first 2 patients, (patients 1 and 2), operative procedure was not modified. One patient suffered from "small-for-size syndrome" and the other died of sepsis with progressive deterioration of graft function. In the rest 22 patients (patients 3 to 24), however, the procedure of venous reconstruction was modified, and better results were obtained. Complications occurred in 7 recipients including acute rejection (2 patients), hepatic artery thrombosis (1), bile leakage (1), intestinal bleeding (1), left subphrenic abscess (1), and pulmonary infection (1). One patient with pulmonary infection died of multiple organ failure (MOF). The 22 patients underwent direct anastomosis of the right hepatic vein to the inferior vena cava (IVC), 9 direct anastomosis plus the reconstruction of the right inferior hepatic vein, and 10 direct anastomosis plus the reconstruction of the tributaries of the middle hepatic vein by interposing a GSV graft to provide sufficient venous outflow. Trifurcation of the portal vein was met in 3 patients. Venoplasty or separate anastomosis was performed. The ratio of graft to recipient body weight ranged from 0.72% to 1.17%. Among these patients, 19 had the ratio <1.0% and 4 <0.8%, and the ratio of graft weight to recipient standard liver volume was between 31.86% and 62.48%. Among these patients, 10 had the ratio <50% and 2 <40%. No "small-for-size syndrome" occurred in the 22 recipients who were subjected to modified procedures. CONCLUSIONS:With the modified surgical techniques for the reconstruction of the hepatic vein to obtain an adequate outflow and provide a sufficient functioning liver mass, living donor liver graft in adults using the right lobe can be safe to prevent the "small-for-size syndrome".

Downregulation of Endothelin-1 by Somatostatin Improves Liver Function of Recipients Undergoing Adult-to-adult Living Donor Liver Transplantation.

Attenuation of Acute Phase Shear Stress by Somatostatin Improves Small-for-size Liver Graft Survival.

Efficacy and Safety of Moderately Steatotic Donor Liver in Transplantation.

Impact of Intra-Operative Cholangiography and Parenchymal Resection to Donor Liver Function in Living Donor Liver Transplantation

Initial Clinical Effect of Intraportal Insulin Administration on Liver Graft Regeneration in Adult Patients Underwent Living Donor Right Lobe Liver Transplantation

Role of Basic Studies in Expanding the Donor Pool for Liver Transplantation

Effects of somatostatin on activated rat hepatic stellate cells and its mechanisms

Role Of Splanchnic Hemodynamics In Liver Regeneration After Living Donor Liver Transplantation

Safety Evaluation of Donors for Living-Donor Liver Transplantation in Chinese Mainland: A Single-Center Report

Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors

Modified techniques for adult-to-adult living donor liver transplantation.

Marginal donor liver versus standard donor liver: A single center-observational study

Effects of Somatostatin-14 and -8 on Portal Hemodynamics in Patients with Portal Hypertension after Intrahepatic Portosystemic Shunt

Effect of Somatostatin Versus Octreotide on Portal Haemodynamics in Patients with Cirrhosis and Portal Hypertension.

Adult-to-adult Living Donor Liver Transplantation: a Report of 71 Cases

Infusion of Nonmyeloablative Bone Marrow Alleviates Acute Rejection Reaction in Liver Allotransplantation

Donor Diabetes and Steatosis Affects Recipient Survival Following Liver Transplantation Based on Etiology of Liver Cirrhosis

Dimethyloxalylglycine pretreatment of living donor alleviates both donor and graft liver ischemia-reperfusion injury in rats

Post-Operative Complications in Living Liver Donors: A Single-Center Experience in China.

A Significant Expansion of CD8+ CD28− T-Suppressor Cells in Adult-to-Adult Living Donor Liver Transplant Recipients

Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody